INTC — Intel Corp.

Market sentiment is constructive but not euphoric. The Q2 2026 beat (revenue $16.1B, +25% YoY; non-GAAP EPS $0.42 vs. GAAP -$2.16), 59% growth in Data Center/AI revenue, and better 18A yields are positive, yet the stock is well off its high and below the $95 offering price. Analysts are polarized: 32 buys, 46 holds, 7 sells, with targets ranging from $60 to $200, keeping the tone neutral-to-cautiously-optimistic.

The trend is a clear upward inflection. Revenue bottomed around $12.7B in early 2025, then progressively recovered to $13.7B by late 2025 and jumped to $16.1B in Q2 2026, up 25% YoY. More importantly, operating income swung from -$3.2B in Q2 2025 to +$2.0B in Q2 2026, and free cash flow improved from -$1.5B to +$4.45B. That said, trailing-twelve-month operating margin is still only about 0.1%, and Q2 2026 GAAP net income included a massive -$11.0B loss driven by non-cash charges, so the fundamental story is real but still early-stage.

Expensive on current fundamentals. With a TTM EPS of -$2.21, the trailing P/E is negative, and the forward P/E is roughly 61x consensus FY2026 EPS of $1.50. Price-to-sales is 8.1x versus a 5-year average of 2.6x, and price-to-book is 5.4x. Given that TTM operating margin is near zero, the market is paying a premium for the turnaround story, not for earnings that have already arrived.

The stock is pricing 2027-2028 success rather than near-term GAAP earnings. At $92.09, it embeds roughly 61x this year's consensus EPS, which only makes sense if EPS can grow from ~$1.50 today to $2.50+ as 18A scales and data center/AI demand stays strong. The August 2026 $95 offering is a useful reference point: institutions bought the stock at $95, so the current price is slightly below that 'smart money' entry level—but it also means a failed execution story would leave no valuation cushion.

As of 2026-08-27, RSI stood at 44.28, which is neutral rather than oversold. The stock traded 3.98% below its 20-day SMA and 12.76% below its 50-day SMA, but 26.97% above its 200-day SMA—a pullback within a longer-term uptrend. That suggests the medium-term trend is still intact but the short-term action is weak; a better entry would be a stabilization above $88 or a reclaim of the 50-day moving average.

• AI infrastructure spending is shifting from pure training to inference and agentic workloads, which Intel says could increase CPU attach rates significantly alongside accelerators.
• Geopolitical pressure to build a U.S.-based leading-edge logic foundry gives Intel a unique policy and national-security tailwind versus TSMC-centric supply chains.
• The semiconductor cycle appears to be inflecting upward after a 2024 trough, with cloud/data-center spending recovering and PC demand stabilizing.
• Massive capital intensity—Intel guided 2026 capex to $20B—will pressure free cash flow and returns even if revenue growth continues.
• Advanced packaging and substrate supply constraints, plus potential export controls or trade restrictions, create both risks and pricing power for domestic foundry capacity.

• Q3 2026 earnings in late October: market will scrutinize operating cash flow, gross margin progression, and foundry external-customer disclosures.
• Intel 18A high-volume manufacturing readiness and any new external foundry customer wins; 14A defect reduction momentum.
• Deployment of the $20B+ equity raise into EMIB-T packaging and substrate capacity, enabling higher-value AI accelerators.
• Continued Data Center and AI revenue acceleration from products like Diamond Rapids and Crescent Island.
• Potential CHIPS Act disbursements or additional government funding for domestic fabrication.

• Execution risk on 18A/14A: any yield or timeline miss would hit both the foundry thesis and core product competitiveness.
• Dilution risk: the $20B equity offering at $95, with potentially more capital raises ahead, will continue to pressure per-share value.
• Core market share loss to AMD, NVIDIA, and ARM-based server/PC chips could limit the margin recovery.
• Balance-sheet stress: stockholders' equity fell from $111.4B to $87.5B in one quarter, and GAAP losses remain large.
• Valuation air-pocket: at ~61x forward EPS and 8.1x sales, any disappointment could trigger a sharp re-rating downward.

Intel is a high-risk, high-reward turnaround with genuine momentum: Q2 2026 revenue and free cash flow inflected sharply, 18A yields are reportedly ahead of plan, and AI/Data Center demand is accelerating. I lean Bullish relative to the deterministic fundamentals score, but this is not a margin-of-safety value stock—it is a priced-for-success turnaround that requires continued flawless execution around 18A, foundry customers, and cash generation.

I applied a 65x forward P/E to consensus FY2026 EPS of $1.498, above Intel's roughly 50x three-year average P/E to reflect the Q2 2026 acceleration in revenue and operating cash flow plus 18A foundry optionality, but below the more aggressive sell-side targets because current operating margins are still near zero and dilution is heavy. Cross-checking: roughly $2.55 of 2027 EPS at 38x gives a similar value, so the fair price is not dependent on a single extreme multiple.